The Schall Law Firm, a national firm specializing in shareholder rights litigation, has announced a class action lawsuit against Intellia Therapeutics, Inc. (“Intellia” or “the Company”), NTLA. The lawsuit alleges violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.

Investors who purchased securities of the Company from July 30, 2024, to January 8, 2025, inclusive (referred to as the “Class Period”), are encouraged to reach out to the firm before April 14, 2025, for participation in the lawsuit.

If you experienced financial losses as a shareholder, click here to participate.

Interested shareholders can contact Brian Schall at the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. He can be reached at 310-301-3335 for a free consultation. In addition, inquiries can be sent via the firm’s website at www.schallfirm.com or through email at [email protected].

It is important to note that the class has not yet received certification. Until this process is completed, you are not represented by an attorney. Should you choose not to take action, you will remain an absent class member.

The Complaint alleges that Intellia made false and misleading representations to the market. The Company created a misleading impression by suggesting it had reliable data regarding the development and marketing of its drug, NTLA-3001. Reports on the timelines for future studies were unsustainable due to high costs and ineffective delivery methods. Additionally, the Company struggled to provide timely doses of NTLA-3001 and maintain adequate staffing. Consequently, public statements made by the Company were materially misleading throughout the class period, leading to investor losses once the truth emerged.

You are encouraged to join the case to recover your losses.

The Schall Law Firm represents global investors and focuses on securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in certain jurisdictions in accordance with applicable laws and ethical standards.

View source version on businesswire.com:
https://www.businesswire.com/news/home/20250414298966/en/

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

[email protected]